AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
Provided By PR Newswire
Last update: Mar 25, 2024
NORTH CHICAGO, Ill. and NEW YORK, March 25, 2024 /PRNewswire/ -- AbbVie Inc. (NYSE: ABBV) ("AbbVie") and Landos Biopharma, Inc. (NASDAQ: LABP) ("Landos") today announced a definitive agreement under which AbbVie will acquire Landos, a clinical stage biopharmaceutical company focused on the development of novel, oral therapeutics for patients with autoimmune diseases. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like receptor family) with a bimodal mechanism of action (MOA), which is anti-inflammatory and facilitates epithelial repair.
Read more at prnewswire.com192.34
+6.28 (+3.38%)
Find more stocks in the Stock Screener
ABBV Latest News and Analysis
5 hours ago - ChartmillThese S&P500 stocks are moving in today's sessionCurious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
8 hours ago - ChartmillExploring the top movers within the S&P500 index during today's session.Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Monday as we examine the latest happenings in today's session.
3 days ago - ChartmillGet insights into the top movers in the S&P500 index of Friday's pre-market session.Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
19 days ago - ChartmillWhat's going on in today's session: S&P500 moversStay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
19 days ago - ChartmillThese S&P500 stocks are gapping in today's sessionLet's have a look at the S&P500 gap up and gap down stocks in today's session.
19 days ago - ChartmillStay updated with the S&P500 stocks that are on the move in today's pre-market session.Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
